(NASDAQ: MRUS) Merus Nv's forecast annual revenue growth rate of 94.93% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 49.64%, and it is also forecast to beat the US market's average forecast revenue growth rate of 11.58%.
Merus Nv's revenue in 2025 is $35,932,000.On average, 6 Wall Street analysts forecast MRUS's revenue for 2025 to be $4,288,633,442, with the lowest MRUS revenue forecast at $2,117,581,653, and the highest MRUS revenue forecast at $6,212,394,414. On average, 6 Wall Street analysts forecast MRUS's revenue for 2026 to be $7,246,538,315, with the lowest MRUS revenue forecast at $279,331,818, and the highest MRUS revenue forecast at $21,613,984,092.
In 2027, MRUS is forecast to generate $19,823,179,588 in revenue, with the lowest revenue forecast at $557,979,000 and the highest revenue forecast at $65,054,189,686.